07:00 , May 10, 2010 |  BC Week In Review  |  Company News

BioMS management update

BioMS Medical Corp. (TSX:MS), Edmonton, Alberta   Business: Autoimmune, Cancer   Hired: Nitin Kaushal as EVP and managing director  ...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Company News

AutoImmune autoimmune news

AutoImmune said its board approved a plan to dissolve the company and liquidate its assets. Shareholders will vote on the proposal at a special meeting, which is expected in 2Q10. The company plans to distribute...
08:00 , Mar 8, 2010 |  BC Week In Review  |  Financial News

Spectral Diagnostics completes private placement of units

Spectral Diagnostics Inc. (TSX:SDI), Toronto, Ontario   Business: Diagnostic   Date completed: 3/3/10   Type: Private placement of units   Raised: C$19.5 million (US$18.6 million)   Units: 48.8 million   Price: C$0.40   Shares after...
08:00 , Mar 8, 2010 |  BioCentury  |  Finance

Ebb & Flow

Adventrx Pharmaceuticals Inc. (NYSE-A:ANX) fell $0.09 (30%) to $0.20 on Monday after FDA refused to file an NDA for ANX-530 to treat non-small cell lung cancer (NSCLC) because of a problem with CMC data from...
00:59 , Mar 4, 2010 |  BC Extra  |  Financial News

Spectral Diagnostics raises C$19.5 million

Spectral Diagnostics Inc. (TSX:SDI) raised C$19.5 million ($18.6 million) through the sale of 48.8 million units at C$0.40 in a previously announced private placement to BioMS Medical Corp. (TSX:MS) and affiliates of GrowthWorks. Each unit...
08:00 , Jan 4, 2010 |  BC Week In Review  |  Clinical News

Dirucotide: Development discontinued

BioMS will discontinue development of dirucotide following a review of Phase III data. In September, Eli Lilly and Co. (NYSE:LLY, Indianapolis, Ind.) returned rights for the program to BioMS after dirucotide missed the primary endpoint...
08:00 , Jan 4, 2010 |  BC Week In Review  |  Company News

BioMS autoimmune news

BioMS restructured and reduced headcount by 50% to reduce expenses. Director of Finance Brent Johnston will replace CFO Don Kimak, who will depart. BioMS, which had 30 employees and contract personnel at year end 2008,...
08:00 , Jan 4, 2010 |  BC Week In Review  |  Financial News

Spectral Diagnostics proposes private placement of units

Spectral Diagnostics Inc. (TSX:SDI), Toronto, Ontario   Business: Diagnostic   Date announced: 12/17/09   Type: Private placement of units   To be raised: C$14 million ($13.2 million)   Units: 35 million   Placement agent: Desjardins...
08:00 , Jan 4, 2010 |  BioCentury  |  Finance

Restructuring watch

Restructuring watch Date Company Staff cuts Cash Years cash pre-cut Cash date Oper loss for 9 mos ended 9/30 10/28/09 SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) 17% to 34 $34.6 2.60 9/30/09 $10.0 Cuts primarily in R&D;...
08:00 , Jan 4, 2010 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 12/31 cls BioMS Medical Corp. (TSX:MS) Hapoalim Raghuram Selvaraju Upgrade Hold (from sell) -4% C$0.33 Rodman Elemer Piros Upgrade Market perform (from underperform) Selvaraju...